Novavax to sell Czech manufacturing unit to Novo Nordisk for $200 million

U.S.-based vaccine maker Novavax (NVAX) said on Wednesday it will sell its manufacturing facility in the Czech Republic to Wegovy maker Novo Nordisk (NVO) for $200 million and use the proceeds for its vaccine pipeline.